Spallanzani: 113 hospitalized, 48 positive. "By mid-July vaccine trial"

2020-06-26T11:08:30.371Z

113 patients are admitted to the Spallanzani Institute in Rome. Of these, "48 are positive for the Sars-CoV-2 research buffer, 65 are investigated," reads today's Spallanzani bulletin. On the other hand, "4 patients need intensive care". "There are 489 patients discharged and transferred to home or to other territorial structures", concludes the bulletin. "We are in the clinical phase I. We have already prepared the premises, we are recruiting healthy citizens and by mid-July the" Covid "vaccine will start testing at the Institute for infectious diseases Lazzaro Spallanzani in Rome. To make the point, speaking to 'Buongiorno Regione' on 'Rai Tre', is the health director of the Imi Spallanzani of Rome, Francesco Vaia. "The virus - added Vaia - has started to circulate within some outbreaks mainly due to a human error, to precautionary measures not carried out correctly".